Histone deacetylase 2 in the mouse hippocampus: Attenuation of age-related increase by caloric restriction

Current Alzheimer Research

Volumn 10, Issue 8, 2013, Pages 868-876

  Chouliaras, Leonidas ^a   van den Hove, Daniel L A ^a,b   Kenis, Gunter ^a   van Draanen, Michael ^a   Hof, Patrick R ^c   van Os, Jim ^a,d   Steinbusch, Harry W M ^a   Schmitz, Christoph ^e   Rutten, Bart P F ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF MUNICH   (Germany)

Author keywords

Aging; Caloric restriction; Epigenesis; Hippocampus; Histone deacetylase 2 (HDAC2)

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; HISTONE DEACETYLASE 2;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALORIC RESTRICTION; CELLULAR DISTRIBUTION; DENTATE GYRUS; DNA METHYLATION; EPIGENETICS; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA2 REGION; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

AGING; ANIMALS; CALORIC RESTRICTION; HIPPOCAMPUS; HISTONE DEACETYLASE 2; MALE; MICE;

EID: 84888046689     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/1567205011310080009     Document Type: Article

References (54)

1. Hof PR, Morrison JH. The aging brain: morphomolecular senescence of cortical circuits. Trends Neurosci 2710: 607-13 (2004).
2. Rutten BP, Schmitz C, Gerlach OH, Oyen HM, de Mesquita EB, Steinbusch HW, et al. The aging brain: accumulation of DNA damage or neuron loss? Neurobiol Aging 281: 91-8 (2007).
3. Dickstein DL, Kabaso D, Rocher AB, Luebke JI, Wearne SL, Hof PR. Changes in the structural complexity of the aged brain. Aging Cell 63: 275-84 (2007).
4. VanGuilder HD, Farley JA, Yan H, Van Kirk CA, Mitschelen M, Sonntag WE, et al. Hippocampal dysregulation of synaptic plasticity-associated proteins with age-related cognitive decline. Neurobiol Dis 431: 201-12 (2011).
5. Berchtold NC, Cribbs DH, Coleman PD, Rogers J, Head E, Kim R, et al. Gene expression changes in the course of normal brain aging are sexually dimorphic. Proc Natl Acad Sci U S A 10540: 15605-10 (2008).
6. Lee CK, Weindruch R, Prolla TA. Gene-expression profile of the ageing brain in mice. Nat Genet 253: 294-7 (2000).
7. Lu T, Pan Y, Kao SY, Li C, Kohane I, Chan J, et al. Gene regulation and DNA damage in the ageing human brain. Nature 4296994: 883-91 (2004).
8. Chouliaras L, Rutten BP, Kenis G, Peerbooms O, Visser PJ, Verhey F, et al. Epigenetic regulation in the pathophysiology of Alzheimer's disease. Prog Neurobiol 904: 498-510 (2010).
9. Chouliaras L, van den Hove DL, Kenis G, Dela Cruz J, Lemmens MA, van Os J, et al. Caloric restriction attenuates age-related changes of DNA methyltransferase 3a in mouse hippocampus. Brain Behav Immun 254: 616-623 (2011).
10. Chouliaras L, van den Hove DL, Kenis G, Keitel S, Hof PR, van Os J, et al. Prevention of age-related changes in hippocampal levels of 5-methylcytidine by caloric restriction. Neurobiol Aging 33(8): 1672-81 (2012).
11. Chouliaras L, van den Hove DL, Kenis G, Keitel S, Hof PR, Van Os J, et al. Age-related increase in levels of 5-hydroxymethylcytosine in mouse hippocampus is prevented by caloric restriction. Curr Alzheimer Res 9(5): 536-44 (2012).
12. Chouliaras L, Sierksma AS, Kenis G, Prickaerts J, Lemmens MA, Brasnjevic I, et al. Gene-environment interaction research and transgenic mouse models of Alzheimer's disease. Int J Alzheimers Dis, 2010, 2010.
13. Colman RJ, Anderson RM, Johnson SC, Kastman EK, Kosmatka KJ, Beasley TM, et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 3255937: 201-4 (2009).
14. Halagappa VK, Guo Z, Pearson M, Matsuoka Y, Cutler RG, Laferla FM, et al. Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease. Neurobiol Dis 261: 212-20 (2007).
15. Sohal RS, Weindruch R. Oxidative stress, caloric restriction, and aging. Science 2735271: 59-63 (1996).
16. Katewa SD, Kapahi P. Dietary restriction and aging Aging Cell 2010 92: 105-12 (2009).
17. Borg J, London J. Copper/zinc superoxide dismutase overexpression promotes survival of cortical neurons exposed to neurotoxins in vitro. J Neurosci Res 702: 180-9 (2002).
18. Cadet JL, Sheng P, Ali S, Rothman R, Carlson E, Epstein C. Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J Neurochem 621: 380-3 (1994).
19. Cardozo-Pelaez F, Song S, Parthasarathy A, Epstein CJ, Sanchez-Ramos J. Attenuation of age-dependent oxidative damage to DNA and protein in brainstem of Tg Cu/Zn SOD mice. Neurobiol Aging 194: 311-6 (1998).
20. Rutten BP, Steinbusch HW, Korr H, Schmitz C. Antioxidants and Alzheimer's disease: from bench to bedside (and back again). Curr Opin Clin Nutr Metab Care 56: 645-51 (2002).
21. Kouzarides, T. Chromatin modifications and their function. Cell 1284: 693-705 (2007).
22. Stilling RM, Fischer A. The role of histone acetylation in ageassociated memory impairment and Alzheimer's disease. Neurobiol Learn Mem 961: 19-26 (2011).
23. Fischer A, Sananbenesi F, Mungenast A, Tsai LH. Targeting the correct HDAC(s) to treat cognitive disorders. Trends Pharmacol Sci 3112: 605-17 (2010).
24. Fischer A, Sananbenesi F, Wang X, Dobbin M, Tsai LH. Recovery of learning and memory is associated with chromatin remodelling. Nature 4477141: 178-82 (2007).
25. Peleg S, Sananbenesi F, Zovoilis A, Burkhardt S, Bahari-Javan S, Agis-Balboa RC, et al. Altered histone acetylation is associated with age-dependent memory impairment in mice. Science 3285979: 753-6 (2010).
26. Guan JS, Haggarty SJ, Giacometti E, Dannenberg JH, Joseph N, Gao J, et al. HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 4597243: 55-60 (2009).
27. Graff J, Rei D, Guan JS, Wang WY, Seo J, Hennig KM, et al. An epigenetic blockade of cognitive functions in the neurodegenerating brain. Nature 4837388: 222-6 (2012).
28. Govindarajan N, Agis-Balboa RC, Walter J, Sananbenesi F, Fischer A. Sodium Butyrate Improves Memory Function in an Alzheimer's Disease Mouse Model When Administered at an Advanced Stage of Disease Progression. J Alzheimers Dis 26(1): 187-97 (2011).
29. Ricobaraza A, Cuadrado-Tejedor M, Perez-Mediavilla A, Frechilla D, Del Rio J, Garcia-Osta A. Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an Alzheimer's disease mouse model. Neuropsychopharmacology 347: 1721-32 (2009).
30. Sinn, D. I., S. J. Kim, K. Chu, K. H. Jung, S. T. Lee, E. C. Song, et al. Valproic acid-mediated neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation. Neurobiol Dis 262: 464-72 (2007).
31. Petri S, Kiaei M, Kipiani K, Chen J, Calingasan NY, Crow JP, et al. Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 221: 40-9 (2006).
32. Rutten BP, Brasnjevic I, Steinbusch HW, Schmitz C. Caloric restriction and aging but not overexpression of SOD1 affect hippocampal volumes in mice. Mech Ageing Dev 2010 1319: 574-9 (2010).
33. Epstein CJ, Avraham KB, Lovett M, Smith S, Elroy-Stein O, Rotman G, et al. Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome. Proc Natl Acad Sci U S A 8422: 8044-8 (1987).
34. Weichert, W., A. Roske, S. Niesporek, A. Noske, A. C. Buckendahl, M. Dietel, et al. Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo. Clin Cancer Res 146: 1669-77 (2008).
35. Franklin KB, Paxinos G. The Mouse Brain in Stereotaxic Coordinates. 1997: Academic Press, San Diego.
36. Miller KM, Tjeertes JV, Coates J, Legube G, Polo SE, Britton S, et al. Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining. Nat Struct Mol Biol 179: 1144-51 (2010).
37. Rutten BP, Korr H, Steinbusch HW, Schmitz C. The aging brain: less neurons could be better. Mech Ageing Dev 1243: 349-55 (2003).
38. Mastroeni D, Grover A, Delvaux E, Whiteside C, Coleman PD, Rogers J. Epigenetic changes in Alzheimer's disease: decrements in DNA methylation. Neurobiol Aging 3112: 2025-37 (2010).
39. Mastroeni D, McKee A, Grover A, Rogers J, Coleman PD. Epigenetic differences in cortical neurons from a pair of monozygotic twins discordant for Alzheimer's disease. PLoS One 48: e6617 (2009).
40. Zeng Y, Tan M, Kohyama J, Sneddon M, Watson JB, Sun YE, et al. Epigenetic enhancement of BDNF signaling rescues synaptic plasticity in aging. J Neurosci 3149: 17800-10 (2011).
41. Tang B, Dean B, Thomas EA. Disease-and age-related changes in histone acetylation at gene promoters in psychiatric disorders. Transl Psychiatry 1: e64 (2011).
42. Walker MP, Laferla FM, Oddo SS, Brewer GJ. Reversible epigenetic histone modifications and Bdnf expression in neurons with aging and from a mouse model of Alzheimer's disease. Age (Dordr), 2012.
43. Caspi A, Moffitt TE. Gene-environment interactions in psychiatry: joining forces with neuroscience. Nat Rev Neurosci 77: 583-90 (2006).
44. Lahiri DK, Maloney B. The "LEARn" (Latent Early-life Associated Regulation) model integrates environmental risk factors and the developmental basis of Alzheimer's disease, and proposes remedial steps. Exp Gerontol 454: 291-6 (2010).
45. Lahiri DK, Maloney B, Zawia NH. The LEARn model: an epigenetic explanation for idiopathic neurobiological diseases. Mol Psychiatry 1411: 992-1003 (2009).
46. Zhang Y, Ng HH, Erdjument-Bromage H, Tempst P, Bird A, Reinberg D. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev 1315: 1924-35 (1999).
47. Dobosy JR, Selker EU. Emerging connections between DNA methylation and histone acetylation. Cell Mol Life Sci 585-6: 721-7 (2001).
48. Bordone L, Cohen D, Robinson A, Motta MC, van Veen E, Czopik A, et al. SIRT1 transgenic mice show phenotypes resembling calorie restriction. Aging Cell 66: 759-67 (2007).
49. Chen D, Bruno J, Easlon E, Lin SJ, Cheng HL, Alt FW, et al. Tissue-specific regulation of SIRT1 by calorie restriction. Genes Dev 2213: 1753-7 (2008).
50. Wakeling LA, Ions LJ, Ford D. Could Sirt1-mediated epigenetic effects contribute to the longevity response to dietary restriction and be mimicked by other dietary interventions? Age (Dordr) 314: 327-41 (2009).
51. Przedborski S, Jackson-Lewis V, Kostic V, Carlson E, Epstein CJ, Cadet JL. Superoxide dismutase, catalase, and glutathione peroxidase activities in copper/zinc-superoxide dismutase transgenic mice. J Neurochem 585: 1760-7 (1992).
52. Montgomery RL, Hsieh J, Barbosa AC, Richardson JA, Olson EN. Histone deacetylases 1 and 2 control the progression of neural precursors to neurons during brain development. Proc Natl Acad Sci U S A10619: 7876-81 (2009).
53. Akhtar MW, Raingo J, Nelson ED, Montgomery RL, Olson EN, Kavalali ET, et al. Histone deacetylases 1 and 2 form a developmental switch that controls excitatory synapse maturation and function. J Neurosci 2925: 8288-97 (2009).
54. Jawerka M, Colak, D. Dimou L, Spiller C, Lagger S, Montgomery RL, et al. The specific role of histone deacetylase 2 in adult neurogenesis. Neuron Glia Biol 62: 93-107 (2010).